hydrazine has been researched along with Disease Models, Animal in 119 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (14.29) | 18.7374 |
| 1990's | 7 (5.88) | 18.2507 |
| 2000's | 22 (18.49) | 29.6817 |
| 2010's | 55 (46.22) | 24.3611 |
| 2020's | 18 (15.13) | 2.80 |
| Authors | Studies |
|---|---|
| Amero, P; Bayraktar, E; Coleman, RL; Dasari, SK; Glassman, D; Handley, KF; Ivan, C; Joseph, R; Kim, M; Landesman, Y; Ma, S; Nguyen, N; Powell, RT; Ram, PT; Rodriguez-Aguayo, C; Sobieski, M; Sood, AK; Stephan, C; Stur, E; Umamaheswaran, S; Wen, Y; Westin, SN | 1 |
| Karpenko, O; Kovalenko, S; Krasovska, N; Nosulenko, I; Stavytskyi, V; Voskoboinik, O | 1 |
| Baev, DS; Borisov, SA; Mironov, ME; Rybalova, TV; Shults, EE; Tolstikova, TG | 1 |
| Fukasawa, K; Hanada, K; Hayashi, Y; Hinata, H; Hirai, H; Imai, S; Itoh, F; Ohfusa, R; Takayama, K | 1 |
| Ahmad, S; Ahmed, MN; Amin, MU; Aziz, A; Khan, A; Khan, S; Shal, B | 1 |
| Chen, M; Han, M; Zhang, Y; Zhu, Y | 1 |
| Hao, H; He, Y; Hu, C; Liu, F; Lu, X; Mei, J; Yi, Y; Zou, F | 1 |
| Li, P; Li, Y; Su, D; Tai, W; Tang, B; Wang, X; Wu, C; Zhang, W; Zhang, Y | 1 |
| Kantevari, S; Krishna, VS; Marvadi, SK; Sridhar, B; Srilakshmi Reshma, R; Sriram, D; Surineni, G | 1 |
| Costa, KG; Fighera, MR; Freitas, ML; Furian, AF; Mello, FK; Moreira, MP; Neuberger, B; Oliveira, MS; Royes, LF; Souto, NS; Zorzi, VN | 1 |
| Acharya, A; De Ville, C; Gohil, VM; Greene, HF; Guthrie, LM; Kim, BE; Lopez, FR; Lynch, B; Nunez, E; Petris, MJ; Sacchettini, JC; Shanbhag, V; Silva, A; Snavely, TC; Soma, S; Yuan, S; Zulkifli, M | 1 |
| Elofsson, M; Roy, S; Sharma, P | 1 |
| Heath, BR; Hong, L; Lei, YL; Ljungman, M; Lu, T; Neamati, N; Shrestha, B; Tang, J | 1 |
| Erickson, SW; Gatto, G; Gill, J; Gorlick, R; Kolb, EA; Nevil, G; Roth, M; Smith, M; Teicher, B; Zhang, W | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Abbas, Z; Al-Mshhdani, BA; Arthur, PG; Balog-Alvarez, CJ; Baustista, AP; Bettis, AK; Duong, MN; Grounds, MD; Kornegay, JN; Nghiem, PP; Terrill, JR; Wingate, CD | 1 |
| Amirmozafari, N; Erfani, M; Mazaheri Tehrani, M | 1 |
| Celis, C; Charris, J; De Sanctis, JB; Fernandez, E; Martínez, G; Mayora, S; Mijares, M; Ramírez, H; Rodrigues, J | 1 |
| Baloglu, E; Ding, LW; Doan, NB; Ganesan, TS; Garg, M; Kanojia, D; Kauffman, M; Koeffler, HP; Mayakonda, A; Nagare, RP; S, S; Sadhanandhan, B; Said, JW; Shacham, S; Suresh, S | 1 |
| Geng, Z; Jing, Y; Liu, YL; Tian, HL; Xia, WL; Xu, ZM; Yang, DX; Yang, GY; Yuan, F | 1 |
| Alesutan, I; Amann, K; Auer, T; Boehme, B; Daniel, C; Gollasch, M; Kuhl, D; Lang, F; Lian, X; Luong, TT; Metzler, B; Müller, DN; Musculus, K; Pieske, B; Sacherer, M; Tuffaha, R; Voelkl, J; Zickler, D | 1 |
| Boulet, A; Chan, SSL; Chun, H; Gitlin, JD; Gohil, VM; Kim, BE; Latimer, AJ; Leary, SC; Rahn, JJ; Soma, S; Timbalia, SA; Vicary, AC | 1 |
| Northrop, NA; Yamamoto, BK | 1 |
| Fira, LS; Likhatskiĭ, PG; Medvid', II; Pyla, VP; Shtroblia, AL; Vashkeba, EM | 1 |
| Abbas, Sel-S; Awadallah, FM; Ibrahim, NA; Kamel, G; Said, EG | 1 |
| Kobayashi, J; Kobayashi, M; Kubo, Y; Natsume, H; Ohtake, K; Sonoda, K; Uchida, H; Uchida, M | 1 |
| Alberch, J; Anglada-Huguet, M; Giralt, A; Martín, ED; Xifró, X; Zamora-Moratalla, A | 1 |
| Bouvet, M; Chishima, T; Endo, I; Hiroshima, Y; Hoffman, RM; Maawy, A; Metildi, CA; Miwa, S; Momiyama, M; Murakami, T; Sato, S; Tanaka, K; Uehara, F; Yano, S; Zhang, Y | 1 |
| Bearss, D; Bhalla, KN; Devaraj, SG; Fiskus, W; Iyer, SP; Liu, K; Portier, BP; Shah, B; Sharma, S | 1 |
| Georgieva, SG; Kerkerian-Le Goff, L; Khaindrava, VG; Khakimova, GR; Kozina, EA; Krasnov, AN; Kucheryanu, VG; Ugrumov, MV; Vorobyeva, NE | 1 |
| Liu, T; Shen, H; Xia, W; Yu, H; Zhang, T | 1 |
| Andersson, SB; Bergström, CA; Fagerberg, JH; Pedersen, C; Peterson, EM; Slepenkin, A | 1 |
| Cheng, CY; Gao, WQ; Quan, Y; Shao, J; Xia, L; Xia, W; Yin, S | 1 |
| Alexandre-Moreira, MS; Barreiro, EJ; Barroso, RC; Bispo Júnior, W; Costa, FN; da Silva, TF; Ferreira, FF; Lima, LM; Monteiro, CE; Noël, F; Sudo, RT; Zapata-Sudo, G | 1 |
| Brose, SA; Combs, CK; Ghatak, A; Golovko, MY; Puig, KL; Rebel, AA; Urquhart, SA | 1 |
| Beckwith, KA; Byrd, JC; Guinn, D; Hing, ZA; Johnson, AJ; Lapalombella, R; Lehman, AM; Mantel, R; Smith, LL; Williams, E; Williams, K; Woyach, JA | 1 |
| Almeida, CB; Conran, N; Costa, FF; Costa, FT; Covas, DT; Leonardo, FC; Souza, LE; Werneck, CC | 1 |
| Ahmad, AS; Dang, A; Doré, S; Greene, E; Leclerc, JL; Singh, N; Soshnik-Schierling, L | 1 |
| Chan, CH; Cusack, JC; Ferreiro-Neira, I; Hong, TS; Landesman, Y; Liesenfeld, LF; Penson, T; Senapedis, W; Shacham, S; Torres, NE | 1 |
| Alonge, MM; Dytfeld, D; Jakubowiak, AJ; Jasielec, J; Kandarpa, M; Kauffman, M; Kraftson, SJ; Maxwell, SP; Mayampurath, A; McCauley, D; Rosebeck, S; Shacham, S; Volchenboum, SL | 1 |
| Ahmad, AS; Candelario-Jalil, E; DeMars, KM; Doré, S; Frankowski, JC; Hawkins, KE; Leclerc, JL; Yang, C | 1 |
| Acosta, SA; Borlongan, CV; Carlson, R; De La Peña, I; Kaneko, Y; Landesman, Y; Shacham, S; Tajiri, N; Tamir, S | 1 |
| Agafonov, AP; Bulychev, LE; Galakhova, DO; Glotov, AG; Kabanov, AS; Nesterov, AE; Omigov, VV; Sergeev, AA; Sergeev, AN; Shishkina, LN; Taranov, OS; Titova, KA; Zamedyanskaya, AS | 1 |
| Fu, N; Fu, Y; Shao, J; Shen, F; Xia, W; Yan, A; Yang, X; Zhang, T | 1 |
| Carlson, R; Crabtree, J; Gabbard, J; Howerth, E; Johnson, S; Perwitasari, O; Register, E; Shacham, S; Tamir, S; Tripp, RA; Yan, X | 1 |
| Bogdán, D; Borbély, É; Botz, B; Csepregi, JZ; Helyes, Z; Horváth, Á; Juhász, T; Keeble, J; Kemény, Á; Mátyus, P; Menghis, A; Mócsai, A; Pintér, E; Tékus, V; Zákány, R | 1 |
| Burd, CE; Crochiere, M; Elloul, S; Elnaggar, O; Farren, MR; Hennessey, RC; Kashyap, T; Kendra, K; Klebanov, B; Landesman, Y; Lesinski, GB; Shakya, R; Young, G | 1 |
| Chang, CC; Chen, JC; Day, YJ; Hsu, PH; Lin, YT; Liu, HL | 1 |
| Berglund, D; Bowden, T; Engstrand, T; Fredriksson, F; Lilja, HE; Sellberg, F | 1 |
| Frisbee, JC; Goodwill, AG; James, ME | 1 |
| Babizhayev, MA; Guiotto, A; Kasus-Jacobi, A | 1 |
| Badejo, AM; Casey, DB; Dhaliwal, JS; Hyman, AL; Kadowitz, PJ; Murthy, SN; Nossaman, BD | 1 |
| Beretta, M; Mayer, B; Schmidt, K; Stessel, H; Wenzl, MV; Wölkart, G | 1 |
| Chen, YQ; Ji, TT; Jiang, X; Mei, B; Zhang, DL | 1 |
| Graham, DA; Rush, JW | 1 |
| Ahanchi, SS; Kapadia, MR; Keefer, LK; Kibbe, MR; Murar, J; Oustwani, CS; Saavedra, JE; Tsihlis, ND | 1 |
| Hedenstierna, G; Hjoberg, J; Jonasson, S | 1 |
| Alachkar, A; Brotchie, JM; Jones, OT | 1 |
| Chu, H; de la Maza, LM; Elofsson, M; Keyser, P; Peterson, EM; Slepenkin, A | 1 |
| Fischborn, SV; Potschka, H; Soerensen, J | 1 |
| Abdellatif, KR; Chattopadhyay, M; Kashfi, K; Keefer, LK; Nia, KV; Pruski, A; Velazquez, CA | 1 |
| Abdollahi, M; Amini, M; Ebrahimi, SE; Firouzi, O; Miri, R; Moradi, A; Navidpour, L; Sadeghian, H; Shadnia, H; Shafiee, A; Zahmatkesh, MH | 1 |
| Li, H; Luo, H; Luo, W; Yang, W | 1 |
| Han, M; Liu, J; Liu, Y; Tan, Q; Wang, W; Wang, YY; Zhang, B; Zhang, JM; Zhang, XJ | 1 |
| Hester, RL; Lu, S; Sebai, M; Xiang, L | 1 |
| Applegate, R; Fathali, N; Jadhav, V; Khatibi, NH; Martin, R; Matus, B; Tang, J; Zhang, JH | 1 |
| Andersson, M; Bergstrom, BP; Carroll, FI; Garris, PA; Mithyantha, J; Sanberg, SG | 1 |
| Beard, DA; Frisbee, JC; Wu, F | 1 |
| Llorens, S; Mendizábal, Y; Nava, E | 1 |
| Alam, MM; Amir, M; Khan, SA; Shaquiquzzaman, M | 1 |
| Dobrowolski, P; Doré, S; Kapoor, N; Kim, YT; Langer, J; Li, RC; Maruyama, T; Narumiya, S; Yocum, J; Zhen, G | 1 |
| Baek, JS; Deer, E; Ellett, F; Fang, L; Green, SR; Lee, SH; Lieschke, GJ; Miller, YI; Tsimikas, S; Witztum, JL | 1 |
| Chupakhin, O; Danilova, I; Medvedeva, S; Rantsev, M; Sarapultsev, A; Sarapultsev, P; Sidorova, L | 1 |
| Anrather, J; Burmeister, MA; Cao, X; Davisson, RL; Guruju, MR; Iadecola, C; Peterson, JR; Wang, G; Young, CN | 1 |
| Baumeister, R; Biernat, J; Fatouros, C; Koushika, SP; Mandelkow, E; Mandelkow, EM; Pir, GJ; Schmidt, E | 1 |
| Cheng, CY; Liu, T; Mruk, DD; Shao, J; Silvestrini, B; Wang, B; Xia, W; Xie, QR; Ying, W; Yu, H; Zhang, T | 1 |
| Butcher, JT; Frisbee, JC; Goodwill, AG; Stanley, SC | 1 |
| Gyires, K; Mátyus, P; Mérey, A; Szökő, E; Tábi, T; Tóth, V | 1 |
| Énzsöly, A; Markó, K; Mátyus, P; Németh, J; Petrash, JM; Szökő, É; Tábi, T; Tóth, M; Zelkó, R | 1 |
| Abram, SR; Alexander, BT; Crell, A; Granger, JP; Llinás, MT; Seedek, M | 1 |
| Kawakami, M; Kuroki, M | 1 |
| Dukelow, AM; Joseph, MG; Karachi, TA; McCormack, DG; Mehta, S; Razavi, HM; Weicker, S | 1 |
| Buikema, H; de Zeeuw, D; Gschwend, S; Henning, RH; Pinto, YM; van Gilst, WH | 1 |
| Al-Jammaz, I; Al-Otaibi, B; Amartey, JK; Esguerra, C; Parhar, RS | 1 |
| Ahmed, Z; Batchelor, AM; Cuzner, ML; Garthwaite, G; Garthwaite, J; Goodwin, DA; Hewson, AK; Leeming, K | 1 |
| Cavun, S; Savci, V; Yalcin, M; Yilmaz, MS | 1 |
| Hyun, SY; Jung, JW; Kim, KH; Kim, SY; Kim, YK; Lee, SY; Oh, HR; Oh, JK; Park, C; Park, JH; Ryu, JH | 1 |
| Gobianand, K; Karthikeyan, S; Priya, S; Vijayalakshmi, P; Vivekanandan, P | 1 |
| Feletou, M; Jensen, BL; Leung, GP; Man, RY; Skott, O; Tang, EH; Vanhoutte, PM | 1 |
| Abram, SR; Carter, C; Dearman, J; Hester, RL; Xiang, L | 1 |
| Duatti, A; Faintuch, BL; Faintuch, S; Muramoto, E; Smith, CJ; Teodoro, R | 1 |
| Brown, ML; Cohen, RA; Tesfamariam, B | 1 |
| Hanss, BG; Lewy, JE; Vari, RC | 1 |
| Edberg, KE; Fish, W; Hellerqvist, C; Parker, RA; Sandberg, K; Sundell, H | 1 |
| Bresnahan, BA; Lianos, EA | 1 |
| Chen, X; Cheng, M; Coetzer, TH; Cohen, FE; Flaherty, TM; Hua, H; Kenyon, GL; Lonsdale-Eccles, JD; McKerrow, JH; Morty, RE; Springer, C; Troeberg, L | 1 |
| Haque, R; Iuvone, PM; Nir, I | 1 |
| Armstead, WM | 1 |
| Gironella, M; Iovanna, J; Panés, J; Piqué, JM; Salas, A; Sans, M; Soriano, A | 1 |
| Dill, RE; Dorris, RL; Phillips-Thonnard, I | 1 |
| Carpi, C; Dorigotti, L; Rolandi, R | 1 |
| Frohberg, H | 1 |
| Bonnet, K; Friedhoff, AJ; Rosengarten, H | 1 |
| Wilson, RB | 1 |
| Doyle, K; Feller, DR; Gerhardt, MA; Harrold, MW; Miller, DD; Patil, PN; Romstedt, KJ; Shin, Y | 1 |
| Christoffersen, CA; Johnson, DC; Morrison, DC; Silverstein, R; Turley, BR | 1 |
| Archer, T; Fredriksson, A; Sundström, E | 1 |
| Drózdz, M; Kucharz, EJ; Olczyk, K | 1 |
| Cooper, EH; Cowen, DM; Haase, P; Knowles, JC | 1 |
| Winter, R | 1 |
| Mones, RJ; Pasik, P; Pasik, T; Wilk, S | 1 |
| Garmaise, AB; Kupchik, HZ; Newberne, PM; Rogers, AE; Saravis, CA; Zamcheck, N | 1 |
| Pozharisskiĭ, KM | 1 |
| Newberne, PM; Rogers, AE | 1 |
| Horst, WD; Pool, WR; Spiegel, HE | 1 |
| Bastien, H; Bordes, M; Justrabo, E; Martin, F; Martin, MS; Michiels, R; Viry, B | 1 |
| Cole, JW; McCall, DC | 1 |
| Popenenkova, AZ; Romanovskaia, MG | 1 |
| Allison, T; Goff, WR; Matsumiya, Y | 1 |
2 review(s) available for hydrazine and Disease Models, Animal
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
[Aminoguanidine and other AGE inhibitors].
Topics: Amides; Animals; Arteriosclerosis; Cardiovascular Diseases; Cataract; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Retinopathy; Disease Models, Animal; Drug Design; Glycation End Products, Advanced; Guanidines; Humans; Hydrazines; Hypoglycemic Agents; Thiadiazoles; Thiazoles; Thiazolidines | 2002 |
2 trial(s) available for hydrazine and Disease Models, Animal
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications.
Topics: Aged; Aged, 80 and over; Aldehydes; Aminooxyacetic Acid; Animals; Biological Availability; Carnosine; Cataract; Cornea; Cross-Over Studies; Diabetes Complications; Disease Models, Animal; Drug Administration Schedule; Drug Delivery Systems; Drug Synergism; Female; Glycosylation; Histidine; Humans; Hydrazines; Lubricants; Male; Middle Aged; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Ophthalmoscopy; Rabbits | 2009 |
116 other study(ies) available for hydrazine and Disease Models, Animal
| Article | Year |
|---|---|
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Disease Models, Animal; Female; High-Throughput Screening Assays; Humans; Hydrazines; Mice; Mice, Nude; Ovarian Neoplasms; Phthalazines; Piperazines; Triazoles | 2021 |
Quinazoline-containing Hydrazydes of Dicarboxylic Acids and Products of Their Structural Modification: A Novel Class of Anti-inflammatory Agents.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Dicarboxylic Acids; Disease Models, Animal; Edema; Hydrazines; Inflammation; Quinazolines; Rats; Rats, Wistar | 2021 |
Synthesis of Anti-Inflammatory Spirostene-Pyrazole Conjugates by a Consecutive Multicomponent Reaction of Diosgenin with Oxalyl Chloride, Arylalkynes and Hydrazines or Hydrazones.
Topics: Animals; Anti-Inflammatory Agents; Chemistry Techniques, Synthetic; Chlorides; Combinatorial Chemistry Techniques; Diosgenin; Disease Models, Animal; Edema; Hydrazines; Hydrazones; Mice; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Oxalates; Pyrazoles | 2021 |
Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model.
Topics: Animals; Biological Products; Cachexia; Disease Models, Animal; Hydrazines; Mice; Muscle, Skeletal; Muscular Atrophy; Myostatin; Neoplasms; Oligopeptides; Peptides; Receptors, Ghrelin; Transforming Growth Factors | 2022 |
Ameliorative effect of two structurally divergent hydrazide derivatives against DSS-induced colitis by targeting Nrf2 and NF-κB signaling in mice.
Topics: Animals; Antioxidants; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Hydrazines; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; NF-kappa B | 2022 |
Stemazole Promotes Oligodendrocyte Precursor Cell Survival In Vitro and Remyelination In Vivo.
Topics: Animals; Cell Differentiation; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Hydrazines; Mice; Mice, Inbred C57BL; Myelin Sheath; Oligodendrocyte Precursor Cells; Oligodendroglia; Oxadiazoles; Remyelination | 2022 |
Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer.
Topics: Active Transport, Cell Nucleus; Animals; Carcinoma; Cell Line, Tumor; Cyclin D1; Disease Models, Animal; Heterografts; Humans; Hydrazines; Hydrogels; Karyopherins; Male; Penile Neoplasms; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2023 |
Observing Malondialdehyde-Mediated Signaling Pathway in Cerebral Ischemia Reperfusion Injury with a Specific Nanolight.
Topics: Animals; Carbon; Disease Models, Animal; Hydrazines; Malondialdehyde; Mice; Molecular Structure; Optical Imaging; Photons; Polymers; Quantum Dots; Reperfusion Injury; Signal Transduction | 2020 |
Synthesis, in vitro, and in vivo (Zebra fish) antitubercular activity of 7,8-dihydroquinolin-5(6H)-ylidenehydrazinecarbothioamides.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Design; Humans; Hydrazines; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Quinolones; Structure-Activity Relationship; Thioamides; Tuberculosis; Zebrafish | 2020 |
Neuroprotective effects of thromboxane receptor antagonist SQ 29,548 after pilocarpine-induced status epilepticus in mice.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Fatty Acids, Unsaturated; Female; Glial Fibrillary Acidic Protein; Hippocampus; Hydrazines; Mice; Motor Activity; Neurons; Neuroprotective Agents; Pilocarpine; Proto-Oncogene Proteins c-fos; Receptors, Thromboxane; Status Epilepticus | 2020 |
Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice.
Topics: Animals; Biological Transport; Brain; Cell Line; Copper; Copper Transporter 1; Disease Models, Animal; Electron Transport Complex IV; Hydrazines; Male; Menkes Kinky Hair Syndrome; Mice; Mice, Knockout; Mitochondria; Neurodegenerative Diseases; Rats | 2020 |
Attenuation of
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Cell Line; Cornea; Disease Models, Animal; Epithelial Cells; Humans; Hydrazines; Keratitis; Mice; Mice, Inbred C57BL; Pseudomonas aeruginosa; Pseudomonas Infections; Type III Secretion Systems; Virulence | 2020 |
Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred C57BL; Ovarian Neoplasms; Quinoxalines; RNA, Antisense; Up-Regulation | 2020 |
Initial
Topics: Animals; Bacterial Outer Membrane Proteins; Benzoates; Disease Models, Animal; Escherichia coli Proteins; Female; Humans; Hydrazines; Male; Mice; Multienzyme Complexes; Osteosarcoma; Pyrazoles; Xenograft Model Antitumor Assays | 2021 |
Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy.
Topics: Animals; Antibodies; Biomarkers; Creatine Kinase; Disease Models, Animal; Dogs; Female; Hydrazines; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Neutrophils; Oxidative Stress; Peroxidase; Protein Carbonylation | 2020 |
[
Topics: Animals; Antimicrobial Cationic Peptides; Disease Models, Animal; Drug Stability; Edetic Acid; Escherichia coli; Escherichia coli Infections; Hydrazines; Kidney; Mice; Nicotinic Acids; Radiopharmaceuticals; Technetium; Tissue Distribution | 2021 |
Synthesis and antimalarial and anticancer evaluation of 7-chlorquinoline-4-thiazoleacetic derivatives containing aryl hydrazide moieties.
Topics: A549 Cells; Acetic Acid; Animals; Antimalarials; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Survival; Disease Models, Animal; Humans; Hydrazines; Inhibitory Concentration 50; Malaria; Male; MCF-7 Cells; Mice; Mice, Inbred BALB C; Quinolines; Structure-Activity Relationship; Thiazoles | 2021 |
Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Disease Models, Animal; Doxorubicin; Exportin 1 Protein; Heterografts; Humans; Hydrazines; Karyopherins; Models, Biological; Neoplasm Transplantation; Receptors, Cytoplasmic and Nuclear; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Treatment Outcome; Triazoles; Tumor Cells, Cultured | 2017 |
Adjudin Attenuates Cerebral Edema and Improves Neurological Function in Mice with Experimental Traumatic Brain Injury.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries, Traumatic; Disease Models, Animal; Hydrazines; Indazoles; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Recovery of Function | 2018 |
SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling.
Topics: Animals; Benzamides; Cell Transdifferentiation; Cells, Cultured; Chondrogenesis; Disease Models, Animal; Gene Expression Regulation; Humans; Hydrazines; Immediate-Early Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Knockout, ApoE; Myocytes, Smooth Muscle; NF-kappa B; Osteogenesis; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Renal Insufficiency; Signal Transduction; Vascular Calcification | 2018 |
Elesclomol restores mitochondrial function in genetic models of copper deficiency.
Topics: Animals; Antineoplastic Agents; Biological Transport; Carrier Proteins; Cell Line; Coenzymes; Copper; Copper Transporter 1; Dietary Supplements; Disease Models, Animal; Drug Repositioning; Drugs, Investigational; Electron Transport Complex IV; Fibroblasts; Humans; Hydrazines; Membrane Transport Proteins; Metabolism, Inborn Errors; Mitochondria; Mitochondrial Proteins; Molecular Chaperones; Mutagenesis, Site-Directed; Mutation; Rats; Saccharomyces cerevisiae; Zebrafish; Zebrafish Proteins | 2018 |
Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine.
Topics: Analysis of Variance; Animals; Biogenic Monoamines; Body Temperature; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Gene Expression Regulation; Hippocampus; Hydrazines; Male; Methamphetamine; Oxazepines; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Stress, Psychological | 2013 |
[Studying of hepatoprotective properties of dry extract from apricot leaves on the model of liver lesion by tetrachloromethane].
Topics: Alanine Transaminase; Animals; Carbon Tetrachloride; Catalase; Chemical and Drug Induced Liver Injury; Cholesterol; Disease Models, Animal; Glutathione; Guinea Pigs; Hydrazines; Liver; Plant Extracts; Plant Leaves; Protective Agents; Prunus; Rabbits; Rats; Superoxide Dismutase | 2013 |
Design and synthesis of some 3-substituted-2-[(2,4-dichlorophenoxy)-methyl]quinazolin-4(3H)-one derivatives as potential anticonvulsant agents.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Drug Design; Female; Hydrazines; Lethal Dose 50; Male; Mice; Neurons; Pentylenetetrazole; Quinazolines; Quinazolinones; Seizures; Triazines | 2013 |
Aldehyde dehydrogenase 2 partly mediates hypotensive effect of nitrite on L-NAME-induced hypertension in normoxic rat.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Hydrazines; Hypertension; Male; Mitochondrial Proteins; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitroglycerin; Rats; Rats, Sprague-Dawley; Sodium Nitrite; Time Factors | 2014 |
Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6/1 mouse model of Huntington's disease.
Topics: Animals; Disease Models, Animal; Huntington Disease; Hydrazines; Male; Memory Disorders; Mice; Mice, Inbred CBA; Mice, Transgenic; Motor Skills Disorders; Oxazepines; Receptors, Prostaglandin E, EP1 Subtype | 2014 |
Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system.
Topics: Animals; Antibodies, Anti-Idiotypic; Carcinoembryonic Antigen; Colonic Neoplasms; Disease Models, Animal; Female; Humans; Hydrazines; Mice; Mice, Nude; Mice, SCID; Optical Imaging; Surgery, Computer-Assisted; Transplantation, Heterologous | 2014 |
Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells.
Topics: Animals; Apoptosis; Cells, Cultured; Co-Repressor Proteins; Disease Models, Animal; Enzyme Inhibitors; Female; Histone Acetyltransferases; Histone Demethylases; Histones; Humans; Hydrazines; Leukemia, Myeloid, Acute; Mice, Inbred NOD; Mice, SCID; Nerve Tissue Proteins; Nucleophosmin; RNA, Small Interfering; Stem Cells; Sulfonamides; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Corpus Striatum; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Electrochemistry; Gene Expression Regulation; Hydrazines; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; RNA, Messenger; Substantia Nigra; Tyrosine 3-Monooxygenase | 2014 |
Adjudin protects against cerebral ischemia reperfusion injury by inhibition of neuroinflammation and blood-brain barrier disruption.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Infarction; CD11b Antigen; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hydrazines; Indazoles; Matrix Metalloproteinase 9; Mice; Microglia; Neurologic Examination; Neuroprotective Agents; Nitric Oxide Synthase Type II; Occludin; Reperfusion Injury; Zonula Occludens-1 Protein | 2014 |
Formulation of the microbicide INP0341 for in vivo protection against a vaginal challenge by Chlamydia trachomatis.
Topics: Animals; Anti-Infective Agents; Chlamydia trachomatis; Delayed-Action Preparations; Disease Models, Animal; Female; HeLa Cells; Humans; Hydrazines; Lymphogranuloma Venereum; Mice; Vagina; Vaginal Creams, Foams, and Jellies | 2014 |
Adjudin protects rodent cochlear hair cells against gentamicin ototoxicity via the SIRT3-ROS pathway.
Topics: Animals; Anti-Bacterial Agents; Cells, Cultured; Cochlea; Disease Models, Animal; Epithelium; Gentamicins; Hair Cells, Auditory; Hearing Loss; Hydrazines; Immunohistochemistry; Indazoles; Mice; Mice, Inbred C57BL; Organ of Corti; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Sirtuin 3; Up-Regulation | 2015 |
Novel orally active analgesic and anti-inflammatory cyclohexyl-N-acylhydrazone derivatives.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Hydrazines; Mice; Neuralgia | 2015 |
Brain changes associated with thromboxane receptor antagonist SQ 29,548 treatment in a mouse model.
Topics: Animals; Anxiety; Brain; Bridged Bicyclo Compounds, Heterocyclic; Depression; Disease Models, Animal; Fatty Acids, Unsaturated; Hydrazines; Male; Mice; Mice, Inbred C57BL; Receptors, Thromboxane; Treatment Outcome | 2015 |
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia.
Topics: Adenine; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Humans; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Mice; Piperidines; Pyrazoles; Pyrimidines; Triazoles; Xenograft Model Antitumor Assays | 2015 |
Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea.
Topics: Anemia, Sickle Cell; Animals; Cell Movement; Cyclic N-Oxides; Disease Models, Animal; Free Radical Scavengers; Hemoglobins; Hemolysis; Humans; Hydrazines; Hydroxyurea; Imidazoles; Inflammation; Leukocytes; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide; Nitric Oxide Donors; Primary Cell Culture; Tumor Necrosis Factor-alpha; Viscosity; Water | 2015 |
Intracerebral hemorrhage outcomes following selective blockade or stimulation of the PGE2 EP1 receptor.
Topics: Animals; Astrocytes; Blood-Brain Barrier; Brain; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Gliosis; Hydrazines; Iron; Leukocytes; Male; Mice, Inbred C57BL; Microglia; Neuroimmunomodulation; Neuroprotective Agents; Oxazepines; Receptors, Prostaglandin E, EP1 Subtype; Recovery of Function | 2015 |
XPO1 Inhibition Enhances Radiation Response in Preclinical Models of Rectal Cancer.
Topics: Animals; Apoptosis; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Dose-Response Relationship, Drug; Exportin 1 Protein; Humans; Hydrazines; Inhibitor of Apoptosis Proteins; Karyopherins; Mice; Radiation; Radiation Tolerance; Radiation-Sensitizing Agents; Receptors, Cytoplasmic and Nuclear; Rectal Neoplasms; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10-Dependent Apoptosis by Carfilzomib and Selinexor.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Caspase 10; Caspase 8; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Enzyme Activation; Humans; Hydrazines; Intracellular Space; Mice; Multiple Myeloma; Oligopeptides; Proteasome Inhibitors; Triazoles; Xenograft Model Antitumor Assays | 2016 |
Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke.
Topics: Animals; Blood-Brain Barrier; Brain Infarction; Disease Models, Animal; Endothelial Cells; Gene Expression; Gene Knockout Techniques; Hydrazines; Male; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Neurons; Neutrophil Infiltration; Oxazepines; Permeability; Proteolysis; Rats; Receptors, Prostaglandin E, EP1 Subtype; Stroke; Tight Junction Proteins | 2015 |
A Nuclear Attack on Traumatic Brain Injury: Sequestration of Cell Death in the Nucleus.
Topics: Acrylamides; Active Transport, Cell Nucleus; Animals; Brain; Brain Injuries, Traumatic; Cell Death; Cell Nucleus; Cell Survival; Cells, Cultured; Disease Models, Animal; Forkhead Transcription Factors; Hydrazines; Male; Motor Activity; Neuroimmunomodulation; Neuroprotective Agents; NF-kappa B; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Recovery of Function; Repressor Proteins; Tumor Necrosis Factor-alpha | 2016 |
[THE USE OF THE MODEL MOUSE ICR--VARIOLA VIRUS FOR EVALUATION OF ANTIVIRAL DRUG EFFICACY].
Topics: Administration, Intranasal; Alkenes; Animals; Antiviral Agents; Benzamides; Disease Models, Animal; Epithelial Cells; Humans; Hydrazines; Isoindoles; Lung; Macrophages, Alveolar; Mice; Mice, Inbred ICR; Smallpox; Variola virus; Viral Load; Virus Replication | 2016 |
Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cytokines; Disease Models, Animal; Fatty Acids, Unsaturated; Gliosis; Hydrazines; Macrophage Activation; Mice, Inbred ICR; Receptors, Thromboxane A2, Prostaglandin H2; Reperfusion Injury; Stroke; Treatment Outcome | 2016 |
Antiviral Efficacy of Verdinexor In Vivo in Two Animal Models of Influenza A Virus Infection.
Topics: Acrylamides; Active Transport, Cell Nucleus; Animals; Antiviral Agents; Disease Models, Animal; Female; Ferrets; Hydrazines; Influenza A virus; Male; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Virus Replication; Virus Shedding | 2016 |
Analgesic and Anti-Inflammatory Effects of the Novel Semicarbazide-Sensitive Amine-Oxidase Inhibitor SzV-1287 in Chronic Arthritis Models of the Mouse.
Topics: Amine Oxidase (Copper-Containing); Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Arthritis; Cells, Cultured; Chronic Disease; Disease Models, Animal; Disease Progression; Freund's Adjuvant; Humans; Hydrazines; Joints; Mice; Mice, Inbred Strains; Mice, Transgenic; Oxazoles; Oximes | 2017 |
The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint Inhibitors.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; B7-H1 Antigen; Cell Line, Tumor; CTLA-4 Antigen; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Exportin 1 Protein; Humans; Hydrazines; Immunomodulation; Karyopherins; Melanoma, Experimental; Mice; Neoplasms; Receptors, Cytoplasmic and Nuclear; T-Lymphocytes; Triazoles | 2017 |
Activation of NPFFR2 leads to hyperalgesia through the spinal inflammatory mediator CGRP in mice.
Topics: Animals; Calcitonin Gene-Related Peptide; Carrageenan; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Forelimb; Freund's Adjuvant; Ganglia, Spinal; Gene Expression Regulation; Hydrazines; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelitis; Neurons; Neurotransmitter Agents; Oxygen; Pain Measurement; Receptors, G-Protein-Coupled; Time Factors | 2017 |
Sutures impregnated with carbazate-activated polyvinyl alcohol reduce intraperitoneal adhesions.
Topics: Anastomosis, Surgical; Animals; Cecum; Cytokines; Disease Models, Animal; Hydrazines; Laparotomy; Male; Peritoneum; Polyvinyl Alcohol; Rats; Rats, Sprague-Dawley; Sutures; Tissue Adhesions | 2017 |
Increased vascular thromboxane generation impairs dilation of skeletal muscle arterioles of obese Zucker rats with reduced oxygen tension.
Topics: Animals; Arterioles; Bridged Bicyclo Compounds, Heterocyclic; Cyclooxygenase Inhibitors; Disease Models, Animal; Enzyme Inhibitors; Epoprostenol; Fatty Acids, Unsaturated; Free Radical Scavengers; Hydrazines; Hypoxia; Imidazoles; Indomethacin; Male; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Obesity; Oxidative Stress; Polyethylene Glycols; Rats; Rats, Zucker; Receptors, Thromboxane; Superoxide Dismutase; Thromboxane A2; Thromboxane-A Synthase; Up-Regulation; Vasodilation | 2008 |
Pulmonary vasodilator responses to sodium nitrite are mediated by an allopurinol-sensitive mechanism in the rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Allopurinol; Animals; Blood Pressure; Cardiac Output; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydrazines; Hypoxia; Injections, Intravenous; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; Oxypurinol; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Sodium Nitrite; Time Factors; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Xanthine Oxidase | 2009 |
Different effects of ascorbate deprivation and classical vascular nitrate tolerance on aldehyde dehydrogenase-catalysed bioactivation of nitroglycerin.
Topics: Aldehyde Dehydrogenase; Animals; Ascorbic Acid; Ascorbic Acid Deficiency; Biotransformation; Chloral Hydrate; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Drug Tolerance; Enzyme Activation; Enzyme Inhibitors; Female; Guinea Pigs; Hydrazines; Injections, Subcutaneous; Isoflavones; Male; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Time Factors; Vasodilation; Vasodilator Agents | 2009 |
Oxidative damage increased in presenilin1/presenilin2 conditional double knockout mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Animals; Deoxyguanosine; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glutathione; Hydrazines; Lipid Peroxidation; Malondialdehyde; Mice; Mice, Inbred CBA; Mice, Knockout; Oxidation-Reduction; Oxidative Stress; Peptide Fragments; Presenilin-1; Presenilin-2; Spectrophotometry, Atomic; Superoxide Dismutase | 2009 |
Cyclooxygenase and thromboxane/prostaglandin receptor contribute to aortic endothelium-dependent dysfunction in aging female spontaneously hypertensive rats.
Topics: Acetylcholine; Age Factors; Aging; Animals; Aorta; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Fatty Acids, Unsaturated; Female; Hydrazines; Hypertension; Indomethacin; Male; Membrane Proteins; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Epoprostenol; Receptors, Thromboxane A2, Prostaglandin H2; Sex Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2009 |
Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury.
Topics: Animals; Aorta, Abdominal; Blotting, Western; Carotid Artery Injuries; Cell Death; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Humans; Hydrazines; Hyperplasia; Immunohistochemistry; Male; Muscle, Smooth, Vascular; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Tunica Intima; Umbilical Veins | 2010 |
Concomitant administration of nitric oxide and glucocorticoids improves protection against bronchoconstriction in a murine model of asthma.
Topics: Administration, Inhalation; Animals; Anti-Asthmatic Agents; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Bronchoconstrictor Agents; Cyclic GMP; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Female; Glucocorticoids; Guanylate Cyclase; Hydrazines; Hydrocortisone; Injections, Intraperitoneal; Lipopolysaccharides; Methacholine Chloride; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Ovalbumin; Oxadiazoles; Pneumonia; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Receptors, Glucocorticoid; Respiration, Artificial; Respiratory Mechanics; Soluble Guanylyl Cyclase | 2010 |
Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Brain Chemistry; Disease Models, Animal; Dopamine Agents; Drug Combinations; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Hydrazines; Hyperkinesis; Levodopa; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Reserpine; Serotonin Receptor Agonists | 2010 |
Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae.
Topics: Administration, Intravaginal; Animals; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Disease Models, Animal; Female; Gonorrhea; HeLa Cells; Humans; Hydrazines; Lactobacillus; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Vagina | 2010 |
Targeting the prostaglandin E2 EP1 receptor and cyclooxygenase-2 in the amygdala kindling model in mice.
Topics: Amygdala; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Hydrazines; Kindling, Neurologic; Male; Mice; Oxazepines; Receptors, Prostaglandin E, EP1 Subtype | 2010 |
Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as safe anti-inflammatory, analgesic, antipyretic, antioxidant prodrugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antipyretics; Aspirin; Dinoprostone; Disease Models, Animal; Edema; Fever; Gastric Mucosa; Hydrazines; Hyperalgesia; Lipid Peroxidation; Male; Malondialdehyde; Molecular Structure; Prodrugs; Rats; Rats, Wistar; Stomach Ulcer; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2010 |
Design and synthesis of 2-phenoxynicotinic acid hydrazides as anti-inflammatory and analgesic agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Drug Design; Humans; Hydrazines; Inflammation; Male; Mefenamic Acid; Mice; Nicotinic Acids; Pain; Rats; Rats, Wistar | 2010 |
Inhibition of semicarbazide-sensitive amine oxidase attenuates myocardial ischemia-reperfusion injury in an in vivo rat model.
Topics: Amine Oxidase (Copper-Containing); Animals; Blood Pressure; Chromatography, High Pressure Liquid; Disease Models, Animal; Heart Rate; Hydralazine; Hydrazines; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; P-Selectin; Peroxidase; Rats; Rats, Sprague-Dawley; Semicarbazides | 2011 |
Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; CA1 Region, Hippocampal; Dentate Gyrus; Disease Models, Animal; Dose-Response Relationship, Drug; Hydrazines; Injections; Memory Disorders; Neurons; Neuroprotective Agents; Oxadiazoles; Peptide Fragments; Protein Multimerization; Protein Structure, Secondary; Rats; Rats, Wistar | 2011 |
Improved functional vasodilation in obese Zucker rats following exercise training.
Topics: Analysis of Variance; Animals; Arachidonic Acid; Blood Glucose; Body Weight; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Eating; Electric Stimulation; Exercise Therapy; Fatty Acids, Unsaturated; Glucose Tolerance Test; Hydrazines; Insulin Resistance; Male; Muscle, Skeletal; Obesity, Morbid; Oxygen Consumption; Rats; Rats, Zucker; Receptors, Thromboxane; Recovery of Function; Time Factors; Vasoconstriction; Vasodilation | 2011 |
Prostaglandin E2 EP1 receptor inhibition fails to provide neuroprotection in surgically induced brain-injured mice.
Topics: Animals; Brain Edema; Brain Injuries; Cell Death; Disease Models, Animal; Dose-Response Relationship, Drug; Functional Laterality; Hydrazines; Male; Mice; Nervous System Diseases; Neuroprotective Agents; Neurosurgical Procedures; Oxazepines; Receptors, Prostaglandin E, EP1 Subtype; Time Factors; Treatment Failure | 2011 |
Functional reorganization of the presynaptic dopaminergic terminal in parkinsonism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dopamine; Electric Stimulation; Electrochemistry; Functional Laterality; Hydrazines; Male; Oxidopamine; Parkinsonian Disorders; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Time Factors; Tropanes | 2011 |
Computational analyses of intravascular tracer washout reveal altered capillary-level flow distributions in obese Zucker rats.
Topics: Albumins; Animals; Bridged Bicyclo Compounds, Heterocyclic; Capillaries; Computer Simulation; Cyclic N-Oxides; Disease Models, Animal; Endovascular Procedures; Fatty Acids, Unsaturated; Hydrazines; Iodine Radioisotopes; Male; Models, Animal; Models, Biological; Muscle, Skeletal; Obesity; Phentolamine; Rats; Rats, Zucker; Regional Blood Flow; Spin Labels | 2011 |
Effects of pioglitazone and rosiglitazone on vascular function of mesenteric resistance arteries in rat genetic hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endothelium, Vascular; Epinephrine; Fatty Acids, Unsaturated; Hydrazines; Hypertension; Hypoglycemic Agents; Indomethacin; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitroprusside; Pioglitazone; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rosiglitazone; Thiazolidinediones; Thromboxane A2; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 2011 |
Synthesis and anticonvulsant activity of some 2-(2-{1-[substituted phenyl]ethylidene}hydrazinyl)-4-(4-methoxy-phenyl)-6-oxo-1,6-dihydro-pyrimidine-5-carbonitrile.
Topics: Animals; Anticonvulsants; Behavior, Animal; Central Nervous System Depressants; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Female; Hydrazines; Male; Mice; Nitriles; Pentylenetetrazole; Pyrimidines; Rotarod Performance Test; Seizures; Structure-Activity Relationship | 2012 |
PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Brain; Brain Ischemia; Calcium; Cells, Cultured; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glucose; Hippocampus; Humans; Hydrazines; Hypoxia; Male; Mice; Mice, Transgenic; Neurons; Neurotoxicity Syndromes; Oxazepines; Peptide Fragments; Presenilin-1; Receptors, Prostaglandin E, EP1 Subtype | 2012 |
In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish.
Topics: Animals; Animals, Genetically Modified; Antibodies, Monoclonal; Anticholesteremic Agents; Blood Vessels; Cholesterol, Dietary; Disease Models, Animal; Drug Evaluation, Preclinical; Epitopes; Genes, Reporter; Green Fluorescent Proteins; Humans; Hydrazines; Hypercholesterolemia; Immunoglobulin Fab Fragments; Lipoproteins, LDL; Macrophages; Malondialdehyde; Microscopy, Confocal; Microscopy, Fluorescence; Oxidation-Reduction; Porphobilinogen; Probucol; Recombinant Fusion Proteins; Single-Chain Antibodies; Temperature; Veins; Zebrafish; Zebrafish Proteins | 2011 |
New insights in to the treatment of myocardial infarction.
Topics: Animals; Aspartate Aminotransferases; Coronary Stenosis; Creatine Kinase; Disease Models, Animal; Hydrazines; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Rats; Rats, Inbred Strains | 2012 |
Angiotensin II-dependent hypertension requires cyclooxygenase 1-derived prostaglandin E2 and EP1 receptor signaling in the subfornical organ of the brain.
Topics: Angiotensin II; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Hydrazines; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxazepines; Reactive Oxygen Species; Receptor Cross-Talk; Receptors, Prostaglandin E, EP1 Subtype; Signal Transduction; Subfornical Organ | 2012 |
Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
Topics: Animals; Animals, Genetically Modified; Axonal Transport; Blood-Brain Barrier; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Disease Models, Animal; Humans; Hydrazines; Methylene Blue; Mitochondria; Motor Neurons; Mutation; Neurons; Neuroprotective Agents; Phenotype; Phosphorylation; Protein Structure, Tertiary; Sensory Receptor Cells; tau Proteins; Tauopathies; Thiazoles; Vesicle-Associated Membrane Protein 1 | 2012 |
Adjudin attenuates lipopolysaccharide (LPS)- and ischemia-induced microglial activation.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Brain Edema; Brain Infarction; CD11b Antigen; Cell Line, Transformed; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hydrazines; Indazoles; Infarction, Middle Cerebral Artery; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Microglia; Nervous System Diseases; NF-kappa B; Psychomotor Performance; Signal Transduction; Time Factors | 2013 |
Blunted temporal activity of microvascular perfusion heterogeneity in metabolic syndrome: a new attractor for peripheral vascular disease?
Topics: Adrenergic alpha-Antagonists; Animals; Antioxidants; Arterioles; Bridged Bicyclo Compounds, Heterocyclic; Cyclic N-Oxides; Disease Models, Animal; Fatty Acids, Unsaturated; Humans; Hydrazines; Male; Metabolic Syndrome; Microvessels; Muscle, Skeletal; Obesity; Oxidative Stress; Peripheral Vascular Diseases; Phentolamine; Rats; Rats, Zucker; Spin Labels | 2013 |
Study on SSAO enzyme activity and anti-inflammatory effect of SSAO inhibitors in animal model of inflammation.
Topics: Amine Oxidase (Copper-Containing); Animals; Arthritis, Experimental; Carrageenan; Disease Models, Animal; Enzyme Inhibitors; Functional Laterality; Gene Expression Regulation, Enzymologic; Hydrazines; Inflammation; Male; Oxazoles; Oximes; Rats; Rats, Wistar; Time Factors | 2013 |
Lack of association between VAP-1/SSAO activity and corneal neovascularization in a rabbit model.
Topics: Amine Oxidase (Copper-Containing); Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Cornea; Corneal Neovascularization; Disease Models, Animal; Drug Interactions; Hydrazines; Male; Rabbits; Suture Techniques; Time Factors | 2013 |
Enhanced thromboxane synthesis during chronic reductions in uterine perfusion pressure in pregnant rats.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Fatty Acids, Unsaturated; Female; Hydrazines; Hypertension; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Rats; Renal Circulation; Thromboxane A2; Uterus | 2002 |
Effects of nebulized diethylenetetraamine-NONOate in a mouse model of acute Pseudomonas aeruginosa pneumonia.
Topics: Acute Disease; Aerosols; Animals; Disease Models, Animal; Hydrazines; Lung; Male; Mice; Mice, Inbred C57BL; Nitrates; Nitric Oxide; Nitrites; Nitroso Compounds; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation | 2002 |
Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Captopril; Chronic Disease; Coronary Vessels; Disease Models, Animal; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Fatty Acids, Unsaturated; Heart; Heart Failure; Hydrazines; Imidazoles; Indomethacin; Lisinopril; Losartan; Male; Mesenteric Arteries; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Superoxide Dismutase; Sympathetic Nervous System; Tetrazoles; Tetrodotoxin; Vascular Resistance | 2003 |
2-[(18)F]-fluoroisonicotinic acid hydrazide: biological evaluation in an acute infection model.
Topics: Animals; Disease Models, Animal; Escherichia coli Infections; Fluorine Radioisotopes; Humans; Hydrazines; Infections; Isonicotinic Acids; Mice; Mice, Inbred BALB C; Radionuclide Imaging; Tuberculosis, Pulmonary | 2004 |
Pathological implications of iNOS expression in central white matter: an ex vivo study of optic nerves from rats with experimental allergic encephalomyelitis.
Topics: 1-Methyl-3-isobutylxanthine; Action Potentials; Animals; Arginine; Biomarkers; CD11b Antigen; CD2 Antigens; Cyclic GMP; DEET; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Encephalomyelitis, Autoimmune, Experimental; Female; Guanylate Cyclase; Guinea Pigs; Hydrazines; Immunohistochemistry; Macrophages; Microscopy, Electron, Transmission; Myelin Basic Protein; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Optic Chiasm; Optic Nerve; Ornithine; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Lew; Time Factors | 2005 |
Activation of the central cholinergic system mediates the reversal of hypotension by centrally administrated U-46619, a thromboxane A2 analog, in hemorrhaged rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cholinergic Fibers; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Fluid; Fatty Acids, Unsaturated; Hemorrhage; Hydrazines; Hypotension; Hypothalamus, Posterior; Injections, Intraventricular; Male; Neural Pathways; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxane A2; Time Factors; Vasoconstrictor Agents | 2006 |
Effects of Anemarrhena asphodeloides on focal ischemic brain injury induced by middle cerebral artery occlusion in rats.
Topics: Anemarrhena; Animals; Biphenyl Compounds; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Free Radical Scavengers; Hydrazines; Immunohistochemistry; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Neuroprotective Agents; Neutrophil Infiltration; Peroxidase; Picrates; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rhizome; Saponins; Time Factors; Triterpenes | 2007 |
Protective effect of picroliv against hydrazine-induced hyperlipidemia and hepatic steatosis in rats.
Topics: Adipose Tissue; Animals; Cholesterol; Cinnamates; Disease Models, Animal; Fatty Acids, Nonesterified; Fatty Liver; Glycosides; Hydrazines; Hyperlipidemias; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Phospholipids; Rats; Rats, Wistar; Triglycerides; Vanillic Acid | 2007 |
The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta, Thoracic; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Fatty Acids, Unsaturated; Hydrazines; Hypertension; Immunohistochemistry; Naphthalenes; Phenylephrine; Potassium Chloride; Propionates; Prostaglandin Antagonists; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Thromboxane; Sulfonamides; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Xanthones | 2008 |
Insulin resistance and impaired functional vasodilation in obese Zucker rats.
Topics: Animals; Antioxidants; Arachidonic Acid; Arterioles; Blood Glucose; Bridged Bicyclo Compounds, Heterocyclic; Cyclic N-Oxides; Disease Models, Animal; Electric Stimulation; Fatty Acids, Unsaturated; Hydrazines; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Resistance; Kidney Cortex; Male; Muscle, Skeletal; NADPH Oxidases; Obesity; Oxidative Stress; Rats; Rats, Zucker; Receptors, Thromboxane; Rosiglitazone; Spin Labels; Superoxides; Thiazolidinediones; Thromboxanes; Time Factors; Triglycerides; Vasoconstriction; Vasodilation | 2008 |
Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
Topics: Animals; Bombesin; Cell Line, Tumor; Cysteine; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Drug Stability; Hydrazines; Hydrophobic and Hydrophilic Interactions; Isotope Labeling; Male; Metabolic Clearance Rate; Mice; Niacinamide; Nitrogen Compounds; Organotechnetium Compounds; Pancreas; Phosphines; Prostate; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin; Tissue Distribution | 2008 |
15-Hydroxyeicosatetraenoic acid and diabetic endothelial dysfunction in rabbit aorta.
Topics: Acetylcholine; Animals; Aorta, Abdominal; Bridged Bicyclo Compounds, Heterocyclic; Cytochrome P-450 Enzyme Inhibitors; Diabetes Mellitus, Experimental; Disease Models, Animal; Endothelium, Vascular; Fatty Acids, Unsaturated; Glucose; Hydrazines; Hydroxyeicosatetraenoic Acids; Imidazoles; Indomethacin; Male; Muscle Contraction; Muscle, Smooth, Vascular; Proadifen; Prostaglandin H2; Prostaglandins H; Rabbits; Radioimmunoassay; Superoxide Dismutase; Thromboxane A2 | 1995 |
Alterations in glomerular dynamics in congenital, unilateral hydronephrosis.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Fatty Acids, Unsaturated; Glomerular Filtration Rate; Hydrazines; Hydronephrosis; Imidazoles; Kidney Glomerulus; Losartan; Male; Rats; Rats, Inbred Strains; Rats, Wistar; Saralasin; Tetrazoles; Thromboxane A2 | 1994 |
Thromboxane receptor blockade (SQ 29,548) in group B streptococcal toxin challenge in young lambs.
Topics: Airway Resistance; Animals; Bacterial Toxins; Bridged Bicyclo Compounds, Heterocyclic; Cardiac Output; Disease Models, Animal; Fatty Acids, Unsaturated; Hemodynamics; Hydrazines; Lung; Pulmonary Gas Exchange; Receptors, Thromboxane; Respiratory Mechanics; Sheep; Streptococcal Infections; Streptococcus agalactiae; Stroke Volume; Thromboxane A2; Vascular Resistance | 1994 |
Effect of thromboxane A2 inhibition and antagonism on prostaglandin and leukotriene synthesis in glomerular immune injury.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Antilymphocyte Serum; Bridged Bicyclo Compounds, Heterocyclic; Dinoprostone; Disease Models, Animal; Fatty Acids, Unsaturated; Glomerulonephritis, Membranoproliferative; Hydrazines; Kidney Glomerulus; Leukotriene B4; Macrophages; Rats; Rats, Wistar; Thromboxane A2; Thromboxane-A Synthase; Thy-1 Antigens | 1999 |
Chalcone, acyl hydrazide, and related amides kill cultured Trypanosoma brucei brucei.
Topics: Amides; Animals; Cathepsin L; Cathepsins; Chalcone; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Disease Models, Animal; Endopeptidases; Humans; Hydrazines; Inhibitory Concentration 50; Kinetics; Mice; Mice, Inbred BALB C; Molecular Structure; Sheep; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis | 2000 |
Diurnal metabolism of dopamine in dystrophic retinas of homozygous and heterozygous retinal degeneration slow (rds) mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Circadian Rhythm; Disease Models, Animal; Dopamine; Enzyme Inhibitors; Heterozygote; Homozygote; Humans; Hydrazines; Intermediate Filament Proteins; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Nerve Tissue Proteins; Peripherins; Phenotype; Photic Stimulation; Photoreceptor Cells; Retina; Retinitis Pigmentosa | 2000 |
Role of altered cyclooxygenase metabolism in impaired cerebrovasodilation to nociceptin/orphanin FQ following brain injury.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Blood; Blood Pressure; Brain Injuries; Bridged Bicyclo Compounds, Heterocyclic; Cerebral Arteries; Cerebrovascular Circulation; Disease Models, Animal; Fatty Acids, Unsaturated; Female; Hydrazines; Indomethacin; Male; Nociceptin; Opioid Peptides; Pia Mater; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Superoxide Dismutase; Swine; Vasodilation | 2000 |
Nitric oxide supplementation ameliorates dextran sulfate sodium-induced colitis in mice.
Topics: Animals; Body Weight; Cell Adhesion; Cell Adhesion Molecules; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelium; Hydrazines; Interferon-gamma; Interleukin-12; Leukocytes; Male; Mice; Mice, Inbred Strains; Nitric Oxide Donors; Nitrogen Oxides; Peroxidase; RNA, Messenger; Venules | 2002 |
A pharmacologic model of Huntington's chorea.
Topics: Animals; Carbachol; Catheterization; Clozapine; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Haloperidol; Huntington Disease; Hydrazines; Levodopa; Male; Phentolamine; Rats; Trifluoperazine; Tyramine | 1976 |
A new antihypertensive compound: 3 hydrazino-6- [(2-hydroxypropyl)methylamino] pyridazine dihydrochloride (ISF 2123).
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Cats; Disease Models, Animal; Dogs; Guinea Pigs; Histamine H1 Antagonists; Hydralazine; Hydrazines; Hypertension, Renal; In Vitro Techniques; Injections, Intravenous; Muscle, Smooth; Parasympatholytics; Pyridazines; Rats; Species Specificity | 1976 |
[Cancerogenesis, teratogenesis, mutagenesis. Relationships between animal experiments and clinical results (author's transl)].
Topics: Animals; Antimetabolites; Carcinogens; Cells; Disease Models, Animal; Embryo, Mammalian; Female; Fertility; Humans; Hydrazines; Imines; Kidney Diseases; Mutagens; Nitrogen Mustard Compounds; Pregnancy; Substance-Related Disorders; Teratogens | 1978 |
Receptor-cell sensitivity modification (RSM) as a model for pathogenesis and treatment of tardive dyskinesia.
Topics: Animals; Carbidopa; Disease Models, Animal; Drug Combinations; Dyskinesia, Drug-Induced; Hydrazines; Levodopa; Rats; Receptors, Dopamine | 1978 |
Species variation in response to dimethylhydrazine.
Topics: Animals; Colonic Neoplasms; Dimethylhydrazines; Disease Models, Animal; Dogs; Guinea Pigs; Hydrazines; Male; Rats; Species Specificity; Swine | 1976 |
Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Death, Sudden; Disease Models, Animal; Fatty Acids, Unsaturated; Humans; Hydrazines; Male; Mice; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Receptors, Prostaglandin; Receptors, Thromboxane; Stereoisomerism; Thromboxane A2; Tretoquinol; Tritium | 1991 |
Hydrazine sulfate protects D-galactosamine-sensitized mice against endotoxin and tumor necrosis factor/cachectin lethality: evidence of a role for the pituitary.
Topics: Animals; Blood Glucose; Corticosterone; Disease Models, Animal; Drug Hypersensitivity; Endotoxins; Female; Galactosamine; Hydrazines; Hypophysectomy; Immunization; Liver; Mice; Mice, Inbred C3H; Phosphoenolpyruvate Carboxykinase (GTP); Pituitary Gland; Premedication; Triiodothyronine; Tumor Necrosis Factor-alpha | 1991 |
Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Body Weight; Corpus Striatum; Disease Models, Animal; Dopamine; Hydrazines; Levodopa; Male; Methyltyrosines; Mice; Mice, Inbred C57BL; Motor Activity; Parkinson Disease, Secondary; Receptors, Dopamine; Stereotyped Behavior | 1990 |
Influence of long-term treatment with hydrazinophthalazines on the activity of lysosomal exoglycosidases in rat tissues.
Topics: Animals; Antibodies, Anti-Idiotypic; Disease Models, Animal; Glycoside Hydrolases; Hydralazine; Hydrazines; Lupus Erythematosus, Systemic; Lysosomes; Male; Organ Specificity; Rats; Rats, Inbred Strains; Reference Values; Todralazine | 1988 |
Evaluation of dimethylhydrazine induced tumours in mice as a model system for colorectal cancer.
Topics: Adenocarcinoma; Animals; Anus Neoplasms; Colonic Neoplasms; Deoxyuridine; Disease Models, Animal; Female; Hydrazines; Injections, Subcutaneous; Iodine Radioisotopes; Liver; Male; Mice; Microscopy, Electron; Mitosis; Polyps; Staining and Labeling | 1973 |
[Studies on the monoamine oxidase inhibiting properties of imidazole derivatives].
Topics: Animals; Brain; Dihydroxyphenylalanine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Hydrazines; Imidazoles; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Muscle Cramp; Rats; Serotonin; Tryptamines | 1973 |
The modification of L-dopa induced dyskinesias in the monkey by unilateral nigral lesions.
Topics: Animals; Caudate Nucleus; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Haplorhini; Hydrazines; Macaca; Movement Disorders; Substantia Nigra | 1973 |
Immunological detection of antigen(s) associated with rat colon carcinoma.
Topics: Adenocarcinoma; Animals; Antigen-Antibody Complex; Antigens, Neoplasm; Carcinoembryonic Antigen; Chromatography, Affinity; Colonic Neoplasms; Disease Models, Animal; Humans; Hydrazines; Immune Sera; Immunodiffusion; Immunoelectrophoresis; Male; Neoplasms, Experimental; Rabbits; Rats; Species Specificity | 1974 |
[Intestinal tumors in rats induced by 1,2-dimethylhydrazine].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Animals; Carcinoma; Disease Models, Animal; Female; Fossil Fuels; Hydrazines; Intestinal Neoplasms; Intestinal Polyps; Intestines; Male; Methods; Neoplasm Metastasis; Neoplasms, Experimental; Rats; Time Factors | 1972 |
Animal model of human disease. Adenocarcinoma of the colon.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Disease Models, Animal; Fossil Fuels; Hydrazines; Neoplasms, Experimental; Rats | 1973 |
Correlation between brain dopamine levels and 1-dopa activity in anti-Parkinson tests.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Blepharoptosis; Brain; Catatonia; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Fever; Humans; Hydrazines; Male; Mice; Mice, Inbred Strains; Norepinephrine; Oxotremorine; Parkinson Disease, Secondary; Reserpine; Time Factors; Tremor | 1973 |
An experimental model for cancer of the colon and rectum. Intestinal carcinoma induced in the rat 1,2-dimethylhydrazine.
Topics: Adenocarcinoma; Animals; Carcinoma; Colonic Neoplasms; Disease Models, Animal; Female; Hydrazines; Intestine, Large; Leiomyosarcoma; Male; Neoplasms, Experimental; Neoplasms, Multiple Primary; Rats; Rats, Inbred Strains; Rectal Neoplasms | 1973 |
Transplantation of chemically induced adenocarcinomas of the colon in an inbred strain in rats.
Topics: Adenocarcinoma; Animals; Carcinogens; Colonic Neoplasms; Disease Models, Animal; Hydrazines; Male; Neoplasm Transplantation; Pedigree; Rats; Rats, Inbred Strains; Transplantation, Homologous | 1974 |
[Effect of aminazin, chloracizin and vetrazine on catecholamines and their metabolism in rats infected with pneumococcus].
Topics: Animals; Catecholamines; Chlorpromazine; Disease Models, Animal; Hydrazines; Methods; Monoamine Oxidase Inhibitors; Phenothiazines; Pneumococcal Infections; Rats; Vasodilator Agents | 1971 |
Effects of convulsive doses of 1,1-dimethylhydrazine on somatic evoked responses in the cat.
Topics: Animals; Brain; Cats; Cerebellar Cortex; Cerebral Cortex; Disease Models, Animal; Electric Stimulation; Electroencephalography; Evoked Potentials; Fossil Fuels; Hippocampus; Hydrazines; Injections, Intraperitoneal; Limbic System; Peripheral Nerves; Seizures; Thalamus | 1970 |